Amylyx Pharmaceuticals, Inc. (AMLX) Net margin 2021–2024
Amylyx Pharmaceuticals, Inc. (AMLX) net profit margin by fiscal year — reported net income divided by reported revenue.
-345.4%FY2024 · since FY2021: -30853.0% → -345.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -345.4% | -358.3 pp |
| FY2023 | 12.9% | +905.3 pp |
| FY2022 | -892.4% | +29960.6 pp |
| FY2021 | -30853.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMLX financial trends
AMLX RevenueAMLX Net incomeAMLX Gross profitAMLX Gross marginAMLX Operating incomeAMLX Operating marginAMLX Operating cash flowAMLX Free cash flowAMLX Capital expendituresAMLX Return on equityAMLX Stock buybacksAMLX Dividends paidAMLX Total assetsAMLX Total liabilitiesAMLX Shareholders’ equityAMLX overview →